ChemoCentryx, the $3.7 billion biotech bought by Amgen in 2022, allegedly ignored repeated warnings from a data monitoring committee and withheld or manipulated trial results on the firm’s ...

Epista Life Science today announced one of the pharmaceutical industry's most comprehensive clinical data remediation programs, a multi-phase initiative spanning more than 800 studies, 43,000 study ...

UMich has expanded its work with pharmaceutical companies in recent years, as they face increased national scrutiny over ...

Supported by Tier Collaboration Dashboards (Tier Boards) and the built-in SAMI (Shiftconnector ® Artificial Manufacturing Intelligence) assistant, eschbach’s Shiftconnector ® addresses this need by ...

In an era where technological innovation is transforming the pharmaceutical and life sciences industry, the importance of workforce development has never been greater. As new drug discovery methods, ...

Microbial testing, analysis and environmental monitoring is fundamental to safe pharmaceutical manufacturing. Regulatory agencies require that the many components of the system implemented, from ...

An announcement from Mayne Pharma Group ( ($AU:MYX) ) is now available. Mayne Pharma Group has released its 2025 Corporate Governance Statement, ...

Pharmaceutical and biotechnology companies generate mountains of data that need to be interpreted into information to make decisions. Knowledge about product quality and patient safety need to be ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced new data for IZERVAY™ (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy ...